OnKure Therapeutics, Inc.
OKURAs of the close on Sep 25, 2026
Price
$2.90
Market cap
—
The cover-page share count does not match the latest report's share count
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How OnKure Therapeutics, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 24, 2026. The latest institutional report shown is dated Dec 31, 2025; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Torren Management, LLC | 2025-12-31 | 504 | $1.46K | SEC filing |
| OSAIC HOLDINGS, INC. | 2024-12-31 | 1,526 | Not shown | SEC filing |
| Tower Research Capital LLC (TRC) | 2024-09-30 | 20,311 | $34.5K | SEC filing |
| BARCLAYS PLC | 2024-09-30 | 228 | $389 | SEC filing |
| BlackRock, Inc. | 2024-09-30 | 221,325 | $376K | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2024-09-30 | 501,534 | $853K | SEC filing |
| JPMORGAN CHASE & CO | 2024-09-30 | 7,668 | $13K | SEC filing |
| MORGAN STANLEY | 2024-09-30 | 64,523 | $110K | SEC filing |
| MORGAN STANLEY | 2024-09-30 | 64,523 | $110K | SEC filing |
| JBF Capital, Inc. | 2024-09-30 | 80,000 | $136K | SEC filing |
| TANG CAPITAL MANAGEMENT LLC | 2024-09-30 | 2,946,260 | $5.01M | SEC filing |
| COMMONWEALTH EQUITY SERVICES, LLC | 2024-09-30 | 19,347 | Not shown | SEC filing |
| SRS Capital Advisors, Inc. | 2024-09-30 | 171 | $291 | SEC filing |
| AMERIPRISE FINANCIAL INC | 2024-09-30 | 49,824 | $84.7K | SEC filing |
| Mirae Asset Global Investments Co., Ltd. | 2024-09-30 | 1,209 | $2.01K | SEC filing |
| RiverVest Venture Management LLC | 2024-09-30 | 2,534,220 | $4.31M | SEC filing |
| CITIGROUP INC | 2024-09-30 | 3,554 | $6.04K | SEC filing |
| Marquette Asset Management, LLC | 2024-09-30 | 73,770 | $125K | SEC filing |
| BANK OF AMERICA CORP /DE/ | 2024-09-30 | 1,212 | $2.06K | SEC filing |
| TWO SIGMA INVESTMENTS, LP | 2024-09-30 | 135,326 | $230K | SEC filing |
- Each value is checked against OnKure Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at OnKure Therapeutics, Inc.'s share price.
- Value not shown for 1 row: no share price from within three months of its report date is on file, so it could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- OSAIC HOLDINGS, INC.: 1,526 shares reported 2024-09-30; 1,526 shares reported 2024-12-31.
- Nantahala Capital Management, LLC: 547,804 shares reported 2024-06-30; 547,804 shares reported 2024-09-30.
- China Universal Asset Management Co., Ltd.: 3,927 shares reported 2024-06-30; 6,429 shares reported 2024-09-30.
- Aldebaran Capital, LLC: 447,616 shares reported 2024-06-30; 452,116 shares reported 2024-09-30.
- CONCOURSE FINANCIAL GROUP SECURITIES, INC.: 0 shares reported 2024-06-30; 0 shares reported 2024-09-30.
- WELLS FARGO & COMPANY/MN: 1,200 shares reported 2024-06-30; 1,200 shares reported 2024-09-30.
- NEA Management Company, LLC: 4,785,494 shares reported 2024-06-30; 4,785,494 shares reported 2024-09-30.
- MILLENNIUM MANAGEMENT LLC: 109,987 shares reported 2024-06-30; 120,565 shares reported 2024-09-30.
- HIGHBRIDGE CAPITAL MANAGEMENT LLC: 2,915,376 shares reported 2024-06-30; 3,062,690 shares reported 2024-09-30.
- TWO SIGMA ADVISERS, LP: 74,900 shares reported 2024-06-30; 226,300 shares reported 2024-09-30.
- BML Capital Management, LLC: 2,672,194 shares reported 2024-06-30; 3,457,395 shares reported 2024-09-30.
- DIMENSIONAL FUND ADVISORS LP: 13,327 shares reported 2024-06-30; 13,327 shares reported 2024-09-30.
Showing the 12 most recent filer reports.
32 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among OnKure Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-05-15 · Hove Anders D: Larger than all 36 other insider purchases of Common Stock on file. SEC filing
- 2025-05-15 · Cormorant Asset Management, LP: Larger than all 15 other insider sales of Class A Common Stock on file. SEC filing
- 2025-05-15 · Hove Anders D: Larger than 33 of the 36 other insider purchases of Common Stock on file. SEC filing
- 2025-05-12 · Cormorant Asset Management, LP: Larger than 14 of the 15 other insider sales of Class A Common Stock on file. SEC filing
- 2024-05-14 · Leonard Braden Michael: Larger than 34 of the 36 other insider purchases of Common Stock on file. SEC filing
- 2021-04-13 · MAKOWER JOSHUA: Larger than 35 of the 36 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2021-08-25–2021-08-25: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2021-04-09–2021-04-13: 4 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-22 | Leverone Jason A. · Chief Financial Officer | Class A Common Stock | S — Open market or private sale | −303 | 4.40 | SEC filing |
| 2026-06-22 | Saccomano Nicholas A · President and CEO | Class A Common Stock | S — Open market or private sale | −86 | 4.40 | SEC filing |
| 2026-03-23 | Saccomano Nicholas A · President and CEO | Class A Common Stock | S — Open market or private sale | −86 | 4.16 | SEC filing |
| 2026-03-23 | Leverone Jason A. · Chief Financial Officer | Class A Common Stock | S — Open market or private sale | −301 | 4.16 | SEC filing |
| 2025-12-22 | Saccomano Nicholas A · President and CEO | Class A Common Stock | S — Open market or private sale | −87 | 2.97 | SEC filing |
| 2025-12-22 | Leverone Jason A. · Chief Financial Officer | Class A Common Stock | S — Open market or private sale | −302 | 2.97 | SEC filing |
| 2025-09-22 | Saccomano Nicholas A · President and CEO | Class A Common Stock | S — Open market or private sale | −88 | 2.62 | SEC filing |
| 2025-09-22 | Leverone Jason A. · Chief Financial Officer | Class A Common Stock | S — Open market or private sale | −303 | 2.62 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-04 | Mathers Edward T · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +7,650 | SEC filing |
| 2026-06-04 | Carruthers R Michael · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +7,650 | SEC filing |
| 2026-06-04 | Ratcliffe Liam · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +1,275 | SEC filing |
| 2026-06-04 | Phillips Andrew John · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +7,650 | SEC filing |
| 2026-06-04 | GREY MICHAEL G · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +7,650 | SEC filing |
| 2026-06-04 | Jansen Valerie Malyvanh · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +7,650 | SEC filing |
| 2026-04-01 | Hartley Dylan · Chief Scientific Officer | Employee Stock Option (right to buy) | A — Grant, award, or other acquisition | +110,000 | SEC filing |
| 2026-04-01 | Leverone Jason A. · Chief Financial Officer | Employee Stock Option (right to buy) | A — Grant, award, or other acquisition | +110,000 | SEC filing |
Showing 8 of 22 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2024-10-07 | Leonard Braden Michael · Other | Common Stock | J — Other acquisition or disposition | +102,076 | SEC filing |
| 2024-10-07 | Leonard Braden Michael · Other | Common Stock | J — Other acquisition or disposition | +345,739 | SEC filing |
Showing 2 of 2 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.